PHARMACOECONOMIC STUDY OF LENVIMA (LENVATINIB) IN ADVANCED PROGRESSIVE RADIO IODINE REFRACTORY DIFFERENTIATED THYROID CANCER IN THE RUSSIAN FEDERATION | Zendy

AI Assistant Blog Pricing

Open Access

PHARMACOECONOMIC STUDY OF LENVIMA (LENVATINIB) IN ADVANCED PROGRESSIVE RADIO IODINE REFRACTORY DIFFERENTIATED THYROID CANCER IN THE RUSSIAN FEDERATION

Author(s) -

M. Yu. Frolov,

В. А. Рогов

Publication year - 2016

Publication title -

farmakoekonomika modern pharmacoeconomics and pharmacoepidemiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.177

H-Index - 3

eISSN - 2070-4933

pISSN - 2070-4909

DOI - 10.17749/2070-4909.2016.9.1.024-032

Subject(s) - lenvatinib , sorafenib , medicine , thyroid cancer , refractory (planetary science) , oncology , cancer , physics , astrobiology , hepatocellular carcinoma

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.